Search - tctmd.com

Displaying 201 - 220 of 383

Sort: Relevancy | Date

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Daily News

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

L.A. McKeown

October 23, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Conference News PCR London Valves 2017

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Shelley Wood

September 28, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

L.A. McKeown

September 07, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Daily News

Delirium’s Dangers Following TAVR: More Evidence

Shelley Wood

July 19, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Presenter: Tamim Nazif

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

Advertisement

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

Delirium’s Dangers Following TAVR: More Evidence

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content